Juno CEO: Changing the way we treat cancer

5:47 PM ET Mon, 11 Dec 2017

CNBC's Meg Tirrell speaks with Hans Bishop, Juno Therapeutics CEO, to discuss the company's down day and progress on its cancer treatment.